ILOPERA

Pharmaceuticals, medical and veterinary preparations for improving exercise capacity and symptoms in NYHA III and IV patients with Primary (idiopathic and familial) pulmonary hypertension and with Pulmonary hypertension due to scleroderma without co-existing interstitial pulmonary and for treatment of patients with advanced Thromboangitis obliterans (Buerger's disease) with critical limb ischemia in whom revascularization is not indicated, treatment of patients with severe peripheral arterial occlusive disease (PAOD), particularly in cases who carry a risk of amputation or cannot undergo angioplasty, treatment of patients with Raynaud's phenomenon irresponsive to other treatments and causing severe restriction; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary medical use, food for babies; dietary supplements for humans and animals; medical plasters, and materials for medical dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides